scorecardresearch
Add as a preferred source on Google
Friday, January 30, 2026
TopicCipla

Topic: Cipla

New injectable to treat complex, antibiotic-resistant UTIs now in India. All about plazomicin

Prevalence of UTIs in Indian population is estimated to be around 33%. Men have less than 15% chance of developing this infection in their lifetime compared to 60% in case of women.

Cipla set to bring Afrezza, 1st inhalable insulin since Exubera, to Indian markets by 2025

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, received CDSCO approval this week.

Who is Jasdeep Singh Gill, new spiritual head of Punjab’s powerful Dera Beas

An IIT Delhi and Cambridge alumnus, Gill will take over from Gurinder Singh Dhillon. Dera Radha Soami Satsang Beas wields significant influence in Punjab.

Cipla’s US unit recalls 6 bronchospasm inhaler batches over container defect

Cipla advises consumers to discontinue use, return or discard the inhalers, and report any adverse reactions to the U.S. health agency.

Godrej, Cipla, Tata— private archives are filling the gaps in the story of modern India

The National Archives of India has almost no record of India's Green Revolution but National Centre for Biological Sciences in Bangalore does.

Using ‘4IR’ tech to beat global challenges — why 4 Indian firms are on WEF’s ‘lighthouses’ list

Cipla, Dr Reddy’s Lab, Mondelez & Unilever lauded for transition to fourth industrial revolution using advanced technologies despite global challenges like Ukraine war & Covid.

Drugmaker Cipla eyes acquisitions in India, US after Covid windfall

Cipla says it's open to mergers & acquisitions. It may partner with smaller firms working on mRNA platforms after the technology came to the fore during the pandemic.

Only boycott of British goods won’t do — Why Abdul Hamied went on to create Cipla

In 'Caring For Life: The Cipla Story Since 1935', Tulsi Vatsal writes about how Khwaja Abdul Hamied wanted to create a science-based industry for India.

Cipla to experiment with Covid drug remdesivir composition to reduce effect on kidneys

Government's subject expert committee asks Cipla to assess renal toxicity of remdesivir's new formulation through a bioequivalence study as well as clinical trials.

India could be producing over 20,000 vials of Remdesivir per day by month-end: Govt data

Remdesivir is now being manufactured by Cipla, Hetero Labs and Mylan. Cipla Wednesday launched the drug under the brand name Cipremi.

On Camera

India-EU FTA will change how US looks at trade with New Delhi. We must be ready

For India and the EU, the reliance on the US for security needs and on China for goods and services is associated with greater risks and vulnerability to major disruptions.

Borrowing to survive: Indian households are saving more, why are they still in debt?

RBI data shows personal loans tripled in six years, with rising slippages; real wages halved as middle class uses loans to maintain lifestyle fuelled by social media.

Indian Army ties up with US drone company that made its name in the Ukraine conflict

Shield AI will provide V-BAT vertical takeoff & landing drones along with licences for software, which will be integrated into aircraft and made available to select Indian partners.

Non-alignment is coming back in a new avatar: Trump-peedit alliance

No nation other than China can negotiate one-on-one with Trump on an equal footing. That’s why the middle powers who so far formed the core of multilateral bodies now feel orphaned.